

Editor’s Note: The future prices of benchmark tracking ETFs and the headline were updated in the story. U.S. stock futures rose on Monday following Friday’s...
You can purchase shares of Entera Bio (NASDAQ:ENTX) through any online brokerage.
Other companies in Entera Bio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Entera Bio has a consensus price target of $9.75.
The stock price for Entera Bio (NASDAQ: ENTX) is $2.9348 last updated October 23, 2026 at 12:27 AM EDT.
There are no upcoming dividends for Entera Bio.
Entera Bio does not have any upcoming earnings scheduled.
There is no upcoming split for Entera Bio.
Entera Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where...